{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:03:04Z","timestamp":1760853784444},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Alpinia Laudanum Institute of Phytopharmaceutical Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1002\/jps.24100","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T15:39:41Z","timestamp":1409326781000},"page":"3139-3152","source":"Crossref","is-referenced-by-count":9,"title":["Mechanism of Chemical Degradation and Determination of Solubility by Kinetic Modeling of the Highly Unstable Sesquiterpene Lactone Nobilin in Different Media"],"prefix":"10.1016","volume":"103","author":[{"given":"Ursula","family":"Thormann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"De Mieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Neuburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheela","family":"Verjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hamburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Imanidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1002\/jps.24100_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms","volume":"15","author":"Dressman","year":"1998","journal-title":"Pharm Res"},{"issue":"9","key":"10.1002\/jps.24100_bb0015","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-009-9927-x","article-title":"Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults","volume":"26","author":"Diakidou","year":"2009","journal-title":"Pharm Res"},{"issue":"3","key":"10.1002\/jps.24100_bb0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification\u2014The correlation of in-vitro drug product dissolution and in-vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"key":"10.1002\/jps.24100_bb0025","series-title":"Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system","author":"FDA","year":"2014"},{"issue":"5","key":"10.1002\/jps.24100_bb0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm Res"},{"issue":"1","key":"10.1002\/jps.24100_bb0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2006.05.004","article-title":"Biorelevant dissolution media as a predictive tool for glyburide a class II drug","volume":"29","author":"Wei","year":"2006","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"10.1002\/jps.24100_bb0040","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1023\/A:1018959511323","article-title":"Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data","volume":"16","author":"Nicolaides","year":"1999","journal-title":"Pharm Res"},{"issue":"1","key":"10.1002\/jps.24100_bb0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2012.12.001","article-title":"An in vitro-in silico-in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: Case example dantrolene","volume":"84","author":"Kambayashi","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"10.1002\/jps.24100_bb0050","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/mp200479f","article-title":"Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of danazol across Caco-2 cell monolayers","volume":"9","author":"Vertzoni","year":"2012","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1002\/jps.24100_bb0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/j.1552-4604.1993.tb04673.x","article-title":"Effect of food and a monoglyceride emulsion formulation on danazol bioavailability","volume":"33","author":"Charman","year":"1993","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1002\/jps.24100_bb0060","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ejpb.2013.10.017","article-title":"Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and fed state and their usefulness","volume":"86","author":"Markopoulos","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1002\/jps.24100_bb0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejpb.2006.08.010","article-title":"Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model","volume":"66","author":"Kapitza","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"10.1002\/jps.24100_bb0070","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/03639045.2011.553618","article-title":"The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems","volume":"37","author":"Sun","year":"2011","journal-title":"Drug Dev Ind Pharm"},{"issue":"25","key":"10.1002\/jps.24100_bb0075","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.biomaterials.2010.04.062","article-title":"The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation","volume":"31","author":"Mohanty","year":"2010","journal-title":"Biomaterials"},{"issue":"4","key":"10.1002\/jps.24100_bb0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejps.2004.11.007","article-title":"In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media","volume":"24","author":"Sunesen","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.24100_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0928-0987(00)00181-0","article-title":"In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs","volume":"11","author":"Dressman","year":"2000","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1002\/jps.24100_bb0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1023\/A:1011071401306","article-title":"Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration","volume":"18","author":"Nicolaides","year":"2001","journal-title":"Pharm Res"},{"issue":"10","key":"10.1002\/jps.24100_bb0095","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1002\/jps.23671","article-title":"Physicochemical characterization, solubilization, and stabilization of 9-nitrocamptothecin using pluronic block copolymers","volume":"102","author":"Saha","year":"2013","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1002\/jps.24100_bb0100","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1023\/A:1015877929381","article-title":"Solubilization and wetting effects of bile-salts on the dissolution of steroids","volume":"8","author":"Bakatselou","year":"1991","journal-title":"Pharm Res"},{"issue":"2","key":"10.1002\/jps.24100_bb0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","article-title":"Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system","volume":"58","author":"Lindenberg","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"10.1002\/jps.24100_bb0110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/jps.2600670810","article-title":"Physicochemical properties of amphoteric beta-lactam antibiotics I: Stability, solubility, and dissolution behavior of amino penicillins as a function of pH","volume":"67","author":"Tsuji","year":"1978","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1002\/jps.24100_bb0115","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1248\/cpb.22.1186","article-title":"Kinetic approach to development in beta-lactam antibiotics. I. comparative stability of semisynthetic penicillins and 6-aminopenicillanic acid in aqueous-solution","volume":"22","author":"Yamana","year":"1974","journal-title":"Chem Pharm Bull"},{"issue":"8","key":"10.1002\/jps.24100_bb0120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jps.2600740805","article-title":"Hydrolysis and solvent-dependent 2\u2032- 5\u2032 and 3\u2032- 5\u2032 acyl migration in prodrugs of 9-beta-D-arabinofuranosyladenine","volume":"74","author":"Anderson","year":"1985","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"10.1002\/jps.24100_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-5173(88)90031-2","article-title":"Preformulation solubility and kinetic-studies of 2\u2032,3\u2032-dideoxypurine nucleosides\u2014Potential anti-aids agents","volume":"45","author":"Anderson","year":"1988","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1002\/jps.24100_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0378-5173(91)90096-7","article-title":"Stability and solubilization of oxathiin carboxanilide, a novel anti-HIV agent","volume":"73","author":"Oh","year":"1991","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1002\/jps.24100_bb0135","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jps.2600790908","article-title":"Physicochemical properties of carbovir, a potential anti-HIV agent","volume":"79","author":"Anderson","year":"1990","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.24100_bb0140","series-title":"Guidance for industry: Food-effect bioavailability and fed bioequivalence studies","author":"FDA","year":"2002"},{"issue":"6","key":"10.1002\/jps.24100_bb0145","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1211\/0022357023583","article-title":"Influence of dissolution media composition on drug release and in-vitro\/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers","volume":"56","author":"Parojcic","year":"2004","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"10.1002\/jps.24100_bb0150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1211\/0022357022935","article-title":"Dissolution media simulating the intralumenal composition of the small intestine: Physiological issues and practical aspects","volume":"56","author":"Vertzoni","year":"2004","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"10.1002\/jps.24100_bb0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2005.08.009","article-title":"Development of an in vitro\/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance","volume":"62","author":"Schamp","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1002\/jps.24100_bb0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/10837451003774377","article-title":"Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement","volume":"16","author":"Murdande","year":"2011","journal-title":"Pharm Dev Technol"},{"issue":"12","key":"10.1002\/jps.24100_bb0165","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/jps.2600581219","article-title":"Amino acid nature of ampicillin and related penicillins","volume":"58","author":"Hou","year":"1969","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.24100_bb0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/21691401.2012.742100","article-title":"Enhanced solubility and oral absorption of sirolimus using D-alpha-tocopheryl polyethylene glycol succinate micelles","volume":"41","author":"Kim","year":"2013","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1002\/jps.24100_bb0175","first-page":"2997","article-title":"Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process","volume":"6","author":"Kim","year":"2011","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"10.1002\/jps.24100_bb0180","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1135\/cccc19771053","article-title":"Isolation and structure of 3-epinobilin, 1,10-epoxynobilin and 3-dehydronobilin\u2014Other sesquiterpenic lactones from flowers of Anthemis nobilis L","volume":"42","author":"Holub","year":"1977","journal-title":"Collect Czechoslov Chem Commun"},{"issue":"8","key":"10.1002\/jps.24100_bb0185","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.tet.2008.11.050","article-title":"Germacrenes A-E and related compounds: Thermal, photochemical and acid induced transannular cyclizations","volume":"65","author":"Adio","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1002\/jps.24100_bb0190","unstructured":"Sigma-Aldrich. DMEM. Accessed August 11, 2014, at: http:\/\/www.sigmaaldrich.com\/Graphics\/COfAInfo\/SigmaSAPQM\/SPEC\/D5\/D5030\/D5030-50L_________SIGMA____.pdf"},{"key":"10.1002\/jps.24100_bb0195","series-title":"Methods in plant biochemistry","first-page":"187","article-title":"Sesquiterpenoid lactones","author":"Fischer","year":"1991"},{"key":"10.1002\/jps.24100_bb0200","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1107\/S0021889807029238","article-title":"SUPERFLIP\u2014A computer program for the solution of crystal structures by charge flipping in arbitrary dimensions","volume":"40","author":"Palatinus","year":"2007","journal-title":"J Appl Crystallogr"},{"key":"10.1002\/jps.24100_bb0205","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1107\/S0021889803021800","article-title":"CRYSTALS version 12: Software for guided crystal structure analysis","volume":"36","author":"Betteridge","year":"2003","journal-title":"J Appl Crystallogr"},{"key":"10.1002\/jps.24100_bb0210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1107\/S0021889812015191","article-title":"Applications of leverage analysis in structure refinement","volume":"45","author":"Parsons","year":"2012","journal-title":"J Appl Crystallogr"},{"key":"10.1002\/jps.24100_bb0215","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1107\/S0021889807067908","article-title":"Mercury CSD 2.0\u2014New features for the visualization and investigation of crystal structures","volume":"41","author":"Macrae","year":"2008","journal-title":"J Appl Crystallogr"},{"key":"10.1002\/jps.24100_bb0220","series-title":"Numerical data fitting in dynamical systems\u2014A practical introduction with applications and software","author":"Schittkowski","year":"2003"},{"issue":"11","key":"10.1002\/jps.24100_bb0225","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0040-4020(01)88464-7","article-title":"Sesquiterpenic acid from leucanthemopsis-pulverulenta","volume":"40","author":"Teresa","year":"1984","journal-title":"Tetrahedron"},{"issue":"1\u20133","key":"10.1002\/jps.24100_bb0230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0003-2670(97)00107-4","article-title":"Application of micellar effects to the simultaneous kinetic determination of pyridoxal and pyridoxal-5\u2019-phosphate","volume":"345","author":"Morales","year":"1997","journal-title":"Anal Chim Acta"},{"issue":"3","key":"10.1002\/jps.24100_bb0235","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0003-2670(94)00230-4","article-title":"Micellar effects on reaction-kinetics part II. Study of the action of dedecyltrimethylammonium bromide on the reactions between pyrogallol red and chromium(VI), vanadium(V) and titanium(IV)","volume":"297","author":"Sicilia","year":"1994","journal-title":"Anal Chim Acta"},{"key":"10.1002\/jps.24100_bb0240","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.molliq.2013.07.003","article-title":"Rate enhancement via micelle encapsulation for room temperature metal catalyzed Ce(IV) oxidation of formaldehyde to formic acid in aqueous medium at atmospheric pressure: A kinetic approach","volume":"186","author":"Ghosh","year":"2013","journal-title":"J Mol Liq"},{"key":"10.1002\/jps.24100_bb0245","unstructured":"Advanced Chemistry Development (ACD\/Labs) Software V11.02 (\u00a9 1994\u20132012 ACD\/Labs). Accessed August 11, 2014, at: https:\/\/scifinder.cas.org."},{"issue":"12","key":"10.1002\/jps.24100_bb0250","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jps.2600711203","article-title":"Effects of surfactants on the aqueous stability and solubility of beta-lactam antibiotics","volume":"71","author":"Tsuji","year":"1982","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1002\/jps.24100_bb0255","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1007\/s11095-013-0999-2","article-title":"Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line Raman spectroscopy and mathematical modeling","volume":"30","author":"Stillhart","year":"2013","journal-title":"Pharm Res"},{"issue":"6","key":"10.1002\/jps.24100_bb0260","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.addr.2007.10.014","article-title":"Enhancing intestinal drug solubilisation using lipid-based delivery systems","volume":"60","author":"Pouton","year":"2008","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915303828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915303828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T13:17:27Z","timestamp":1565788647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915303828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0022354915303828"],"URL":"https:\/\/doi.org\/10.1002\/jps.24100","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}